Is Igc Pharma Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NYSEMKT: IGC) stock is to Buy IGC stock.
Out of 1 analyst, 0 (0%) are recommending IGC as a Strong Buy, 1 (100%) are recommending IGC as a Buy, 0 (0%) are recommending IGC as a Hold, 0 (0%) are recommending IGC as a Sell, and 0 (0%) are recommending IGC as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year IGC price target, the average IGC price target is $4.50, with the highest IGC stock price forecast at $4.50 and the lowest IGC stock price forecast at $4.50.
The Wall Street analyst predicted that Igc Pharma's share price could reach $4.50 by Aug 26, 2026. The average Igc Pharma stock price prediction forecasts a potential upside of 997.56% from the current IGC share price of $0.41.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.